Evidence map›Paper›PMID 40675818›Full record

ArticleGenome research2025

Transcriptional modulation unique to vulnerable motor neurons predicts ALS across species and SOD1 mutations.

Irene Mei, Susanne Nichterwitz, Melanie Leboeuf, Jik Nijssen, Isadora Lenoel, Dirk Repsilber, Christian S Lobsiger, Eva Hedlund

Abstract read
In one paragraph

Article in Genome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Irene MeiDepartment of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.ORCID 0009-0007-8238-6224
Susanne NichterwitzDepartment of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.ORCID 0000-0002-9950-5003
Melanie LeboeufDepartment of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.ORCID 0000-0003-0033-7159
Jik NijssenDepartment of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden.ORCID 0000-0003-0013-9750
Isadora LenoelSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, 75013 Paris, France.ORCID 0009-0008-1096-5902
Dirk RepsilberSchool of Medical Sciences, Örebro University, 701 82 Örebro, Sweden.ORCID 0000-0002-7173-5579
Christian S LobsigerSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, 75013 Paris, France.ORCID 0000-0002-4313-010X
Eva HedlundDepartment of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden; eva.hedlund@dbb.su.se.ORCID 0000-0001-6347-0075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is characterized by the progressive loss of motor neurons (MNs) that innervate skeletal muscles. However, certain MN groups including ocular MNs, are relatively resilient. To reveal key drivers of resilience versus vulnerability in ALS, we investigate the transcriptional dynamics of four distinct MN populations in SOD1G93A ALS mice using LCM-seq and single-molecule fluorescent in situ hybridization. We find that resilient ocular MNs regulate few genes in response to disease. Instead, they exhibit high baseline gene expression of neuroprotective factors, including

Indexed as

Amyotrophic Lateral SclerosisMotor NeuronsMutationSuperoxide Dismutase-1Transcription, GeneticAnimalsDisease Models, AnimalGene Expression RegulationHumansMiceMice, TransgenicTranscriptomeSod1 protein, mouseSuperoxide Dismutase-1

Identifiers

PMID40675818
PMCPMC12400948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.